IRIS
BARBIERI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 210
EU - Europa 68
AS - Asia 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 206
IT - Italia 28
GB - Regno Unito 19
SE - Svezia 11
RU - Federazione Russa 5
CA - Canada 4
AT - Austria 2
CN - Cina 2
CL - Cile 1
DE - Germania 1
EU - Europa 1
IN - India 1
RO - Romania 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 284
Salva come PNG Salva come JPEG
Città #
Chandler 57
Chicago 22
London 18
Lawrence 12
Princeton 11
Ashburn 8
Wilmington 5
Naples 4
Ottawa 4
Des Moines 3
Catanzaro 2
St Petersburg 2
Vienna 2
Boardman 1
Cosenza 1
Hanover 1
Moscow 1
Nalgonda 1
Norwalk 1
Omsk 1
Pitesti 1
Riyadh 1
Rome 1
Roncadelle 1
Saint Louis 1
Siziano 1
Squillace 1
Totale 164
Salva come PNG Salva come JPEG
Nome #
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome 33
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer 30
Whole gene expression profiling shows a differential transcriptional response to CISPLATINUM in BRCA-1 defective versus BRCA1-reconstituted breast cancer cells 28
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 27
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 24
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 22
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 22
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 21
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 21
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 20
Possibility of identification and expression modality of bronchogenic carcinoma 13
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 13
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 12
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 11
Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology 8
Exercise therapy as treatment for oncologic disease after a diagnosis of early-stage cancer: effects on lifestyle 5
null 4
Totale 314
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 1 0 0 0 0 0 3 4
2020/202112 2 0 0 2 0 3 2 0 2 1 0 0
2021/202236 0 0 0 15 0 0 2 3 6 5 4 1
2022/2023156 27 8 10 8 18 14 2 10 23 16 13 7
2023/2024102 37 9 10 9 6 23 2 2 0 1 3 0
Totale 314